达拉图穆马
泊马度胺
医学
多发性骨髓瘤
地塞米松
中性粒细胞减少症
内科学
来那度胺
肿瘤科
化疗
作者
Ajai Chari,Attaya Suvannasankha,Joseph W. Fay,Bertrand Arnulf,Jonathan L. Kaufman,Jainulabdeen J. Ifthikharuddin,Brendan M. Weiss,Amrita Krishnan,Suzanne Lentzsch,Raymond L. Comenzo,Jianping Wang,Kerri Nottage,Christopher Chiu,Nushmia Z. Khokhar,Tahamtan Ahmadi,Sagar Lonial
出处
期刊：Blood
[Elsevier BV]
日期：2017-06-22
卷期号：130 (8): 974-981
被引量：419
标识
DOI：10.1182/blood-2017-05-785246
摘要
Key Points No new safety signals were observed with daratumumab plus pomalidomide and dexamethasone, except for increased neutropenia. Daratumumab plus pomalidomide and dexamethasone induced rapid, deep, and durable responses in heavily treated patients with multiple myeloma.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
CAOHOU
八分饱
YamDaamCaa
碧蓝金针菇
23
冥冥之极为昭昭
风清扬
GingerF
Tsui
代芙
Nico
COSMAO
Xiaoxiao
shiqiang mu
eric888
Moses
打卡下班
乐乐乐乐乐乐
鬼见愁
kk99123
皖公网安备34019202002308
